Wednesday, 29 March 2023 to Thursday, 30 March 2023

Dr Veronique De Conto

Dr Veronique De Conto
Dr Veronique De Conto
Project leader in vitro pharmaco
HCS Pharma
Delegate / Poster Presenter


Profile of Dr Veronique De Conto

I work as a project leader in in vitro pharmacology in HCS Pharma (France). In this company, we have developed BIOMIMESYS®, a disruptive technology for cell culture. This is the first 3D cell culture system which closely reproduces both the physicochemical and the biological properties of the extracellular matrix. BIOMIMESYS® is a hyaluronic acid-based matrix, bio-functionalized with other components of the extracellular matrix. Its composition and stiffness can be adapted to each healthy or diseased organ. This matrix is ready-to-use in multi-well plates. It combines both advantages of hydrogels and solid scaffolds providing adequate support and porosity. In this way, BIOMIMESYS® reproduces all the aspects of microenvironment: matrix architecture, composition and stiffness, cell organization, cell-cell and cell-matrix interactions. Thanks to its expertise, HCS Pharma also provides services in 3D cell culture and phenotypic screening.

You are welcome to meet us in front of our poster (#23)!


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'